European Leukemia Trial Registry
Trial: APL 04-06

More Details
Title Combination Chemotherapy in Treating Patients With Newly Diagnosed APL
Scientific Title A Randomised Phase III Study to Compare Arsenic Trioxide (ATO) Combined to ATRA Versus Standard ATRA and Anthracycline-Based Chemotherapy (AIDA Regimen) for Newly Diagnosed, Non High-Risk Acute Promyelocytic Leukemia
Short Title APL 04-06
Trialgroup GIMEMA
Type of Trial multicentric, randomized
Disease Acute myeloid leukemia(AML) FAB M3 (APL)
Age <= 70 years
Status Closed
Start of Recruitment 01.11.2008
Leader Platzbecker, Prof. Dr. med., Uwe
Centre of Trial Universitätsklinikum Carl Gustav Carus, Dresden
Shortprotocol Shortprotocol
created 25.06.2008 Roswitha Kotthoff
changed 10.07.2013 Sina Hehn
© ELIC European Leukemia Information Center | no responsibility is taken for correctness and completeness of this information | |